BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 25843661)

  • 1. A role of 1,25(OH)2D3 supplementation in rats with nonalcoholic steatohepatitis induced by choline-deficient diet.
    Han H; Cui M; You X; Chen M; Piao X; Jin G
    Nutr Metab Cardiovasc Dis; 2015 Jun; 25(6):556-61. PubMed ID: 25843661
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epigallocatechin gallate attenuated non-alcoholic steatohepatitis induced by methionine- and choline-deficient diet.
    Ding Y; Sun X; Chen Y; Deng Y; Qian K
    Eur J Pharmacol; 2015 Aug; 761():405-12. PubMed ID: 25967348
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antifibrotic Effects of 1,25(OH)
    Ma L; Ishigami M; Honda T; Yokoyama S; Yamamoto K; Ishizu Y; Kuzuya T; Hayashi K; Hirooka Y; Goto H
    Dig Dis Sci; 2019 Sep; 64(9):2581-2590. PubMed ID: 30825110
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polaprezinc attenuates liver fibrosis in a mouse model of non-alcoholic steatohepatitis.
    Sugino H; Kumagai N; Watanabe S; Toda K; Takeuchi O; Tsunematsu S; Morinaga S; Tsuchimoto K
    J Gastroenterol Hepatol; 2008 Dec; 23(12):1909-16. PubMed ID: 18422963
    [TBL] [Abstract][Full Text] [Related]  

  • 5. n-3 polyunsaturated fatty acids worsen inflammation and fibrosis in experimental nonalcoholic steatohepatitis.
    Provenzano A; Milani S; Vizzutti F; Delogu W; Navari N; Novo E; Maggiora M; Maurino V; Laffi G; Parola M; Marra F
    Liver Int; 2014 Jul; 34(6):918-30. PubMed ID: 24628836
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Growth differentiation factor 15 ameliorates nonalcoholic steatohepatitis and related metabolic disorders in mice.
    Kim KH; Kim SH; Han DH; Jo YS; Lee YH; Lee MS
    Sci Rep; 2018 May; 8(1):6789. PubMed ID: 29717162
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA-21 is associated with fibrosis in a rat model of nonalcoholic steatohepatitis and serves as a plasma biomarker for fibrotic liver disease.
    Takeuchi-Yorimoto A; Yamaura Y; Kanki M; Ide T; Nakata A; Noto T; Matsumoto M
    Toxicol Lett; 2016 Sep; 258():159-167. PubMed ID: 27320964
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic calcitriol supplementation improves the inflammatory profiles of circulating monocytes and the associated intestinal/adipose tissue alteration in a diet-induced steatohepatitis rat model.
    Su YB; Li TH; Huang CC; Tsai HC; Huang SF; Hsieh YC; Yang YY; Huang YH; Hou MC; Lin HC
    PLoS One; 2018; 13(4):e0194867. PubMed ID: 29684027
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vitamin B5 and N-Acetylcysteine in Nonalcoholic Steatohepatitis: A Preclinical Study in a Dietary Mouse Model.
    Machado MV; Kruger L; Jewell ML; Michelotti GA; Pereira Tde A; Xie G; Moylan CA; Diehl AM
    Dig Dis Sci; 2016 Jan; 61(1):137-48. PubMed ID: 26403427
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Animal Models of Steatosis (NAFLD) and Steatohepatitis (NASH) Exhibit Hepatic Lobe-Specific Gelatinases Activity and Oxidative Stress.
    Palladini G; Di Pasqua LG; Berardo C; Siciliano V; Richelmi P; Perlini S; Ferrigno A; Vairetti M
    Can J Gastroenterol Hepatol; 2019; 2019():5413461. PubMed ID: 30854350
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The xanthine oxidase inhibitor febuxostat suppresses development of nonalcoholic steatohepatitis in a rodent model.
    Nakatsu Y; Seno Y; Kushiyama A; Sakoda H; Fujishiro M; Katasako A; Mori K; Matsunaga Y; Fukushima T; Kanaoka R; Yamamotoya T; Kamata H; Asano T
    Am J Physiol Gastrointest Liver Physiol; 2015 Jul; 309(1):G42-51. PubMed ID: 25999428
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulatory role of Co-enzyme Q10 on methionine and choline deficient diet-induced non-alcoholic steatohepatitis (NASH) in albino rats.
    Saleh DO; Ahmed RF; Amin MM
    Appl Physiol Nutr Metab; 2017 Mar; 42(3):243-249. PubMed ID: 28177750
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Cholecystokinin Receptor Antagonist Halts Nonalcoholic Steatohepatitis and Prevents Hepatocellular Carcinoma.
    Tucker RD; Ciofoaia V; Nadella S; Gay MD; Cao H; Huber M; Safronenka A; Shivapurkar N; Kallakury B; Kruger AJ; Kroemer AHK; Smith JP
    Dig Dis Sci; 2020 Jan; 65(1):189-203. PubMed ID: 31297627
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pan-caspase inhibitor VX-166 reduces fibrosis in an animal model of nonalcoholic steatohepatitis.
    Witek RP; Stone WC; Karaca FG; Syn WK; Pereira TA; Agboola KM; Omenetti A; Jung Y; Teaberry V; Choi SS; Guy CD; Pollard J; Charlton P; Diehl AM
    Hepatology; 2009 Nov; 50(5):1421-30. PubMed ID: 19676126
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatoprotective and antioxidant activities of extracts from Salvia-Nelumbinis naturalis against nonalcoholic steatohepatitis induced by methionine- and choline-deficient diet in mice.
    Liu Y; Song H; Wang L; Xu H; Shu X; Zhang L; Li Y; Li D; Ji G
    J Transl Med; 2014 Nov; 12():315. PubMed ID: 25406833
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protective effect of ursodeoxycholic acid, resveratrol, and N-acetylcysteine on nonalcoholic fatty liver disease in rats.
    Ali MH; Messiha BA; Abdel-Latif HA
    Pharm Biol; 2016 Jul; 54(7):1198-208. PubMed ID: 26134756
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exogenous Administration of Low-Dose Lipopolysaccharide Potentiates Liver Fibrosis in a Choline-Deficient l-Amino-Acid-Defined Diet-Induced Murine Steatohepatitis Model.
    Nakanishi K; Kaji K; Kitade M; Kubo T; Furukawa M; Saikawa S; Shimozato N; Sato S; Seki K; Kawaratani H; Moriya K; Namisaki T; Yoshiji H
    Int J Mol Sci; 2019 Jun; 20(11):. PubMed ID: 31163617
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elevated free cholesterol in a p62 overexpression model of non-alcoholic steatohepatitis.
    Simon Y; Kessler SM; Gemperlein K; Bohle RM; Müller R; Haybaeck J; Kiemer AK
    World J Gastroenterol; 2014 Dec; 20(47):17839-50. PubMed ID: 25548482
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alpha-lipoic acid attenuates methionine choline deficient diet-induced steatohepatitis in C57BL/6 mice.
    Min AK; Kim MK; Kim HS; Seo HY; Lee KU; Kim JG; Park KG; Lee IK
    Life Sci; 2012 Jan; 90(5-6):200-5. PubMed ID: 22154902
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glycine protects against high sucrose and high fat-induced non-alcoholic steatohepatitis in rats.
    Zhou X; Han D; Xu R; Wu H; Qu C; Wang F; Wang X; Zhao Y
    Oncotarget; 2016 Dec; 7(49):80223-80237. PubMed ID: 27784003
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.